APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Terminated
CT.gov ID
NCT00234273
Collaborator
(none)
10
4
2
43
2.5
0.1

Study Details

Study Description

Brief Summary

The principal objective is to assess and analyze the effects of a six month programme in Adapted Physical Activity (APA) on physical activity, compliance, and insulin resistance among type 2 diabetics.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Rehabilitation programme in Adapted Physical Activity (APA)
  • Behavioral: Therapeutic education primarily focused on dietary
Phase 2

Detailed Description

Clinical trial with direct individual profit. Study phase 2. Study center: University Hospital Grenoble Principal investigator: Pr. Serge HALIMI Sponsor: University Hospital Grenoble

The principal objective is to assess and analyze the effects of a six month programme in Adapted Physical Activity (APA) on physical activity, compliance, and insulin resistance among type 2 diabetics.

Secondary objectives are to assess and analyze the effects of a six month programme in APA of:

  • arterial tension

  • weight, body composition and abdominal perimeter

  • quality of life

  • treatment dosage

  • number of hospitalisation thick a diabetes complication acute for one year and for each patient Compare two exercise's intensity: first lactate threshold (SL1) and crossover (PCGL).

Inclusion criteria:
  • type 2 diabetics

  • age > 40 years

  • first education in Education Diabetics Department of University Hospital Grenoble

  • sedentary patients

  • HbA1c > 7%-

  • BMI > 25

  • to be affiliate disease assurance

  • to give consent written and inform

Judgment criteria for physical activity compliance:
  • leisure time physical activity: Modifiable Activity Questionnaire

  • training note-book

Judgment criteria for resistance insulin:
  • Crossover (PCGL)

  • HOMA and FIRI index

  • HbA1c

Programme test: Rehabilitation programme in Adapted Physical Activity (APA)

Programme test period: 6 months

Study total period: 28 months

Study period for each patient: 18 months

Safety criteria: clinical compendium undesirable events

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Effects Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics Persons
Study Start Date :
Nov 1, 2004
Actual Primary Completion Date :
Jun 1, 2008
Actual Study Completion Date :
Jun 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Therapeutic education combining dietary and rehabilitation

Therapeutic education combining dietary and rehabilitation (APA)

Procedure: Rehabilitation programme in Adapted Physical Activity (APA)

Behavioral: Therapeutic education primarily focused on dietary

Active Comparator: Therapeutic education primarily focused on dietary

Therapeutic education primarily focused on dietary

Behavioral: Therapeutic education primarily focused on dietary

Outcome Measures

Primary Outcome Measures

  1. Increase physical activity compliance long-term [6 months after the beginning of the program]

    Modifiable Activity Questionnaire (MAQ

  2. Lessen insulin resistance [6 months after the beginning of the program]

    HOMA (Homeo-stasis model assessment), HbA1c, PCGL

Secondary Outcome Measures

  1. Improve the quality of life [6 months after the beginning of the program]

    Short Form-36 Health Survey Questionnary (SF-36)

  2. Improve the arterial tension [6 months after the beginning of the program]

    arterial tension

  3. Lessen the weight [6 months after the beginning of the program]

    weight

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Type 2 diabetics

  • Age > 40

  • First education in the Education Diabetics Department of the University Hospital Grenoble

  • Sedentary patients

  • Hemoglobin A1c (HbA1c) > 7%

  • Body mass index (BMI) > 25

  • To be affiliated with disease assurance

  • To give written and informed consent

Exclusion Criteria:
  • Foot sore < six months

  • Renal disease - proteinuria stage

  • Contraindication for exercise

  • VO2 max > 120% Wassermann standard

  • Coronary pathology non-stabilization

  • Arteriopathy stage 2 non-compensation

  • Osteo-articular crippling problem

  • Geographically distant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Endocrinology, Diabetology and Nutrition - University Hospital of Grenoble Grenoble Rhone-alpes France 38000
2 Department of Endocrinology, Diabetology and Nutrition Grenoble Rhône-Alpes France 38000
3 Endocrinology, Diabetology and Nutrition Department - University Hospital of Grenoble Grenoble France 38000
4 HALIMI Serge Grenoble France 38000

Sponsors and Collaborators

  • University Hospital, Grenoble

Investigators

  • Principal Investigator: HALIMI Serge, Institut National de la Santé Et de la Recherche Médicale, France
  • Principal Investigator: Halimi S. Therapeutic strategies for type 2 diabetes. Rev Prat HALIMI, Institut National de la Santé Et de la Recherche Médicale, France

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT00234273
Other Study ID Numbers:
  • DCIC 03 09
First Posted:
Oct 6, 2005
Last Update Posted:
Jun 19, 2013
Last Verified:
Jun 1, 2013

Study Results

No Results Posted as of Jun 19, 2013